Dr Nathan Stanley

Dr Nathan Stanley
  • Biography/ Background

    Research Experience

    Oct 2015 – present

    Postdoctoral Research Fellow

    University of Adelaide, School of Chemical Engineering

    Adelaide, South Australia, Australia

    Mar 2013 – Dec 2014

    Postdoctoral Research Chemist

    CNRS Orleans Campus, Centre de Biophysique Moléculaire (CBM)

    Orléans, Centre, France

    Development of Base-Labile N-Terminal Catch and Release Linkers for Solid Phase Peptide Ligation

    May 2012 – Dec 2012

    Postdoctoral Research Associate

    University of Otago, Department of Chemistry

    Dunedin, New Zealand

    Towards Organic Carbon Monoxide Releasing Molecules with Application for Organ Transplantation

    May 2011 – Apr 2012

    Postdoctoral Research Associate

    University of Otago, Department of Chemistry

    Dunedin, New Zealand

    Synthesis of Mitochondrially-Targeted Diagnostics

    Oct 2010 – Apr 2011

    Synthetic Organic Chemist

    University of Adelaide, Discipline of Chemistry

    Adelaide, South Australia, Australia

    Synthesis and Enantiomeric Resolution of Ketamine and Norketamine

  • Qualifications

    Doctor of Philosophy                      Organic / Medicinal Chemistry                (The University of Adelaide, 2010)

    Bachelor of Science (Honours)      Pharmacology                                           (The University of Adelaide, 2005)

    Bachelor of Science                         Synthetic Chemistry / Pharmacology     (The University of Adelaide, 2004)

  • Publications

    1. Angela Logan, Victoria R. Pell, Karl J. Shaffer, Lesley Larsen, Cameron Evans, Nathan J. Stanley, Ellen L. Robb, Tracy A. Prime, Edward T. Chouchani, Helena M. Cochemé, Ian M. Fearnley, Andrew M. James, Carolyn M. Porteous, Linda Partridge, Thomas Krieg, Robin A. J. Smith, and Michael P. Murphy. Cell Metabolism, 2015, In Press. Assessing the Mitochondrial Membrane Potential in Cells and In Vivo Using Targeted Click Chemistry and Mass Spectrometry.

    2. Yibai Li, Janet K Coller, Mark R Hutchinson, Kathrin Klein, Ulrich M Zanger, Nathan J Stanley, Andrew D Abell, and Andrew A Somogyi. Drug Metabolism & Disposition, 2013, 41, 1264-1272. The CYP2B6*6 Allele Significantly Alters the N-demethylation of Ketamine Enantiomers In Vitro, doi:10.1124/dmd.113.051631.

    3. N.J. Stanley, M.R. Hutchinson, T. Kvist, B. Nielsen, H. Bräuner-Osborne, E.R.T. Tiekink, D.S. Pedersen, A.D. Abell, R.J. Irvine and D.K. Taylor. Bioorganic & Medicinal Chemistry, 2010, 18, 6089-6098. A New Metabotropic Glutamate Receptor Agonist with In Vivo Anti-allodynic Activity, doi:10.1016/j.bmc.2010.06.051.

    4. N.J. Stanley, T. Kvist, B. Nielsen, D.S. Pedersen, H. Bräuner-Osborne, A.D. Abell and D.K. Taylor. Bioorganic & Medicinal Chemistry Letters, 2010, 20, 7512-7515. 1,2,3-Triazolyl Amino Acids as AMPA Receptor Ligands, http://www.sciencedirect.com/scidirimg/clear.gifdoi:10.1016/j.bmcl.2010.09.139.

    5. N. Stanley, A. Salem, R.J. Irvine. Neuroscience, 2007, 146, 321-329. The Effects of Co-administration of 3,4-Methylenedioxymethamphetamine (“Ecstasy”) or Para-Methoxyamphetamine and Moclobemide at Elevated Ambient Temperatures on Striatal 5-HT, Body Temperature and Behaviour in Rats, http://www.sciencedirect.com/scidirimg/clear.gifdoi:10.1016/j.neuroscience.2007.01.012.

     

The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.

Entry last updated: Wednesday, 25 Nov 2015